Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Mass Spectrometry is key technology for studying critical molecules and pathways. Defining molecular targets is crucial for the process of drug development.

Group Lab Retreat in Limassol - Cyprus May 2022 © Not applicable
Kessler Group Lab Retreat Limassol Cyprus May 2022

In our group, we are focused on using proteomics, mass spectrometry and biochemical approaches to understand disease processes.

Proteomics and Mass Spectrometry

The group has expertise in proteomics based methodologies and hosts a platform containing a variety of chromatography equipment and mass spectrometers.

We apply mass spectrometry to discover "molecular windows" of human diseases to accelerate target discovery.

 

Our team

Recent publications

Tracking tau and cellular responses in human iPSC-microglia: from uptake to seedable secretion, including in extracellular vesicles.

Journal article

Karabova MK. et al, (2026), Alzheimer's & dementia : the journal of the Alzheimer's Association, 22

Ubiquitin E3 ligase KLHL6 brings exhausted T-cells back into action

Journal article

Chen Z. et al, (2026), Immunity & Inflammation, 2

Rational discovery of therapeutic PAK1 allosteric activators

Journal article

He Y. et al, (2026), Cell